GRM1 (glutamate metabotropic receptor 1) is a G-protein coupled receptor that binds glutamate and activates phosphatidylinositol-calcium second messenger systems through GNAQ-PLC-PKC signaling pathways 123. The receptor plays crucial roles in synaptic plasticity, including long-term potentiation in the hippocampus and long-term depression in the cerebellum, and modulates ion channel activity in dopaminergic neurons and cerebellar Purkinje cells 45. Beyond its neurological functions, GRM1 has significant oncogenic potential when aberrantly expressed. Gene fusions and rearrangements involving GRM1 serve as key drivers in chondromyxoid fibroma, with up to 1,400-fold overexpression detected in 90% of cases 6. GRM1 fusions also represent alternative molecular drivers in blue nevi and related melanomas, appearing mutually exclusive with classical GNAQ/GNA11 mutations 7. In human melanoma, genetic variants in GRM1 may contribute to disease susceptibility, particularly in patients with low sun exposure and tumors on trunk/extremities 8. The receptor's role in tumorigenesis makes it a potential therapeutic target, with studies demonstrating tumor suppression through GRM1-targeting approaches 9. Additionally, GRM1 has been associated with ADHD pathogenesis, suggesting broader neurodevelopmental roles 10.